ATLANTA - Medical device maker C.R. Bard Inc. has agreed to pay $48.26 million to the federal government to settle False Claims Act allegations that the company paid kickbacks to health care providers to buy its radioactive brachytherapy seeds used to treat prostate cancer, the Justice Department announced May 13 (United States of America, ex rel. Julie Darity v. C.R. Bard, Inc., No. 06-208, N.D. Ga., Atlanta Div.)....(read more)Image may be NSFW.
Clik here to view.
Clik here to view.
